Cowen Prime Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Cowen Prime Advisors’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-25,000	Closed	-$424K	–	354
2014 Q4	$424K	Buy	+25,000	New	+$352K	0.17%	75

Cowen Prime Advisors's AVNR Position: Q1 2015 in Review

Cowen Prime Advisors sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 25,000 shares — an estimated $424K sold.

Cowen Prime Advisors first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $424K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Cowen Prime Advisors reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Cowen Prime Advisors sold 25,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $424K.
Cowen Prime Advisors first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
Cowen Prime Advisors's AVANIR PHARMACEUTICALS, INC CL A position peaked at $424K in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Cowen Prime Advisors's 13F filing for Q1 2015, filed 13 May 2015.